Thu.Dec 28, 2023

article thumbnail

STAT+: UnitedHealth used secret rules to restrict rehab care for seriously ill Medicare Advantage patients

STAT

Health insurance giant UnitedHealth Group used secret rules to restrict access to rehabilitation care requested by specific groups of seriously ill patients, including those who lived in nursing homes or suffered from cognitive impairment, according to internal documents obtained by STAT. The documents, which outline parameters for the clinicians who initially review referrals for rehab care, reveal that many patients enrolled in Medicare Advantage plans were routed for a quick denial based on c

article thumbnail

Pharmacy Staffing Ratios: Balancing Workload and Quality of Care

The Script

Balancing workloads and quality patient care is challenging in the pharmaceutical industry. Learn how to perfect your ratios from Rx relief.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Renamed, common liver diseases might get fairer shake at treatment, researchers hope

STAT

A slate of liver diseases got a rebrand this year. Experts hope the change can generate more conversation — and research interest — for conditions that still lack treatments.  A group of over 200 physicians, public health experts, industry representatives, regulatory officials, and patient advocates made the call in a supermajority vote: Non-alcoholic fatty liver disease, or NAFLD, would be renamed metabolic dysfunction-associated steatotic liver disease.

341
341
article thumbnail

Cell and gene therapy will be top industry trend for pharma in 2024: GlobalData

Express Pharma

Healthcare industry professionals scored cell and gene therapy (CGT) as the industry trend to have the greatest impact on the pharmaceutical industry in 2024, in a recent survey launched by GlobalData. The survey data presented in “The State of the Biopharmaceutical Industry 2024” report reveals that N=21 (18 per cent) of industry professionals were convinced that CGT will dominate as the most important trend in pharma next year.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

JPM Healthcare Conference 2024

STAT

The annual J.P. Morgan Healthcare Conference, the largest event of its kind, will take place in San Francisco, Jan. 8-11, 2024 — setting the stage for the rest of the year in health, science, and medicine. The event is a gathering space for investors, entrepreneurs, and others. Join us at the conference STAT will host an in-person event on Jan. 8 looking at what’s next in biotech.

299
299
article thumbnail

J&J jumps on ADC train, signs $1.7bn licensing deal with LegoChem

Pharmaceutical Technology

J&J has acquired a global license for South Korean LegoChem’s ADC for $100m upfront along with milestone-based payments and tiered royalties.

98

More Trending

article thumbnail

EMCrit 365 – Setting PEEP and Righting the Right Ventricle in ARDS with Matt Siuba

EMCrit Project

Setting PEEP and Righting the RV in ARDS with Matt Siuba EMCrit Project by Scott Weingart, MD FCCM.

119
119
article thumbnail

Leveraging innate cell engagers for lymphoma treatment

European Pharmaceutical Review

In this exclusive interview, Andreas Harstrick, the Chief Medical Officer of Affimed unveils the potential of innate cell engagers for treating lymphoma. As well as presenting recent findings from the pivotal AFM13-104 study, Andreas also reflects on the challenges encountered and conquered in developing Affimed’s innate cell engager, Acimtamig, which targets CD30 on lymphoma cells and CD16A on NK cells.

article thumbnail

BMS bags UK advanced melanoma win for Opdualag

Pharmaceutical Technology

The MHRA gave Bristol Myers Squibb’s Opdualag marketing authorisation for advanced melanoma as part of Project Orbis.

98
article thumbnail

Cytokinetics rockets on positive heart drug trial

pharmaphorum

Cytokinetics rises on report that its aficamten drug improved symptoms in people with rare disease obstructive hypertrophic cardiomyopathy

95
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Cancer test shows promise for bringing the benefits of immunotherapy to more patients

World Pharma News

Brigham researchers' findings from next-generation sequencing suggest that revising current cancer care guidelines could allow approximately 6,000 more patients in the U.S. to benefit from immunotherapy treatment each year. Immunotherapy is a highly effective treatment for patients whose cancers harbor mismatch repair deficiency, and a new study identifies more cancer patients who could benefit from this form of therapy.

85
article thumbnail

Breaking: Judgment in Regeneron v. Mylan (aflibercept) BPCIA Case Finding Some Claims of Asserted Patents Valid and Infringed

Big Molecule Watch

As previously reported by Big Molecule Watch, trial in Regeneron’s BPCIA case against Biocon regarding Biocon’s proposed aflibercept biosimilar concluded on June 15, 2023 in the Northern District of West Virginia. The patents-at-issue are directed to formulations and dosing regimens for aflibercept, an anti-VEGF treatment for retinal disorders including age-related macular degeneration, diabetic macular edema, and diabetic retinopathy.

article thumbnail

Investing in the gleams of positivity and hope for life sciences innovation

pharmaphorum

In this third instalment of the five-part, festive series of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Mark Andrews, investment director of life sciences funds at British Patient Capital (BPC), discussing the vitally hot topic of investment in life sciences.

64
article thumbnail

Year in Review: Top Deals in 2023

Big Molecule Watch

According to PWC , “2023 was a reasonably strong year for the pharmaceutical and life sciences sector with both deal value and volume of M&A close to pre-pandemic levels.” Below is a recap of the top M&A deals in 2023 that focus on biologics and biosimilars and were covered on the Big Molecule Watch. Coya Announces Agreement with Dr. Reddy’s Laboratories for Treatment of Neurodegenerative Diseases In March, Coya Therapeutics, Inc.

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Following these best practices while coding helps providers avoid costly mistakes

pharmaphorum

Medical billing errors have become a significant issue in the healthcare industry, causing financial losses for hospitals, insurers, and even patients. This article explores the impact of such errors in the United States, with a focus on coding and the need for improved systems and processes.

article thumbnail

New patent expiration for Ferring Pharms drug NOCDURNA

Drug Patent Watch

Annual Drug Patent Expirations for NOCDURNA Nocdurna is a drug marketed by Ferring Pharms Inc and is included in one NDA. It is available from one supplier. There are ten… The post New patent expiration for Ferring Pharms drug NOCDURNA appeared first on DrugPatentWatch - Make Better Decisions.

59
article thumbnail

P.R.E.S.C.R.I.B.E.S – The Marketing Methodology for Clinical Service Growth

pharmacy mentor

The Omnichannel Approach In an age where pharmacies are rapidly evolving beyond traditional roles, embracing innovative strategies to stand out and succeed is crucial. With the advent of Pharmacy First and the growing trend of private clinics, pharmacies are at a pivotal point. Enter P.R.E.S.C.R.I.B.E.S , a marketing methodology designed to catapult your pharmacy into the forefront of healthcare services.

52
article thumbnail

New patent for Delcath Systems drug HEPZATO

Drug Patent Watch

Annual Drug Patent Expirations for HEPZATO Hepzato is a drug marketed by Delcath Systems Inc and is included in one NDA. It is available from one supplier. There are nine… The post New patent for Delcath Systems drug HEPZATO appeared first on DrugPatentWatch - Make Better Decisions.

59
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

FH23: Inside the first Digital Medicine & DTx Global Policy Summit

pharmaphorum

Get insights into FH23, the first Digital Medicine & DTx Global Policy Summit, where experts come together to discuss the latest advancements and policies in the digital health and DTx industry. Explore the intersection of technology, medicine, and policy in this global event.

52
article thumbnail

Top 5 Conference Coverage Videos of 2023

Pharmaceutical Commerce

Over the past year, Pharma Commerce’s digital coverage featured a variety of subject matters, ranging from how to calculate 340B prices, to the future of pharmacy.

52
article thumbnail

German Court Invalidates CureVac Patent in Ongoing BioNTech Lawsuit

Big Molecule Watch

On December 19, a German court invalidated CureVac’s messenger RNA technology patent, EP 1 857 122 B1, in a lawsuit brought by CureVac against its rival BioNTech. CureVac, a biopharmaceutical company developing messenger RNA therapeutics for COVID-19 vaccines, announced that it will appeal the decision before the German Federal Court of Justice. This ruling represents the first decision on validity in the ongoing patent litigation between CureVac and BioNTech in Germany.

article thumbnail

Elpiscience and Astellas partner for new macrophage engagers

Pharmaceutical Technology

Elpiscience Biopharma has signed an agreement with Astellas Pharma for two new bispecific macrophage engagers for cancer.

52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Which pharmaceutical drugs have the most drug patents in Costa Rica?

Drug Patent Watch

This chart shows the drugs with the most patents in Costa Rica. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is… The post Which pharmaceutical drugs have the most drug patents in Costa Rica? appeared first on DrugPatentWatch - Make Better Decisions.

45
article thumbnail

Tome brings $213 Million to the Programmable Genome Editing Party

PharmaTech

Tome Bioscience is facilitating the transition in biology from the editing phase to the cut-and-paste phase.

52
article thumbnail

The Top 5 DE&I Stories in 2023

PharmExec

As companies continued to expand their DE&I efforts, Pharm Exec was there to cover it in 2023.

52
article thumbnail

Körber and Franz Ziel Tighten Ties

PharmaTech

Is increasing molecular diversity pushing manufacturing ecosystem consolidation toward turnkey solutions?

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Dow Jones

Pharma and Life Sciences Blog

GEP is a leading global provider of AI-powered consulting, outsourcing and technology solutions to procurement and supply chain organizations at Fortune 500 and Global 2000 enterprises worldwide.

40
article thumbnail

Top 5 Pharmacy Focus Podcasts of 2023

Pharmacy Times

From newsworthy moments to groundbreaking research, these were the most listened-to podcasts on Pharmacy Focus in 2023.

29
article thumbnail

STAT stories you might have missed in 2023

STAT

There’s an old story in journalism, and it goes like this: A reporter is asked, “What’s the best story you’ve ever written?” The reply? “The one I’m doing for tomorrow.” There’s a lot of that at STAT, and that’s why we’ve assembled an in-case-you-missed-it list of great stories from this year.

Hospitals 304
article thumbnail

Top 5 Pharmacy Times Coronavirus Articles of 2023

Pharmacy Times

From newsworthy moments to groundbreaking research, these were the most-read coronavirus-related articles on Pharmacy Times in 2023.

26
article thumbnail

Opinion: Gaza, Ukraine, and other conflicts could be accelerating antibiotic resistance

STAT

In recent months, evidence suggests, the war in  Ukraine  and the ongoing conflict in  Gaza have led to spikes of multidrug-resistant bacterial infections. This is to be expected; conflicts often create conditions that are perfect for drug resistance to emerge and spread, with the first evidence of this dating back as far as the 1940s.

360
360